Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2008
09/18/2008WO2008111669A1 Novel prophylactic and/or therapeutic agent for diabetic neuropathy
09/18/2008WO2008111668A1 Novel prophylactic and/or therapeutic agent for neurogenic pain
09/18/2008WO2008111651A1 Ameliorating or prophylactic agent for metabolic syndrome, and beverage, food and feed each comprising the same
09/18/2008WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
09/18/2008WO2008111520A1 Gene related to life extension and use thereof
09/18/2008WO2008111473A1 Glucokinase activator
09/18/2008WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
09/18/2008WO2008111384A1 Epithelium improving agent
09/18/2008WO2008111244A1 External preparation for skin, and food
09/18/2008WO2008110598A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/18/2008WO2008110551A1 An anti-diabetic extract of rooibos
09/18/2008WO2008110196A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
09/18/2008WO2008110062A1 Compounds with partial agonist activity of pparϝ and application thereof
09/18/2008WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008WO2008092816A3 Novel polymorphic forms of n-piperidino-5-(4-chlorophenyl)-1(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
09/18/2008WO2008089984A3 Process for the preparation of ezetimibe and derivatives thereof
09/18/2008WO2008074832A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
09/18/2008WO2008070496A3 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
09/18/2008WO2008063232B1 Substituted pyrazolopyrimidines
09/18/2008WO2008014470A3 Adult sertoli cells and uses thereof
09/18/2008US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
09/18/2008US20080227865 Reducing digestion of lipids to treat or prevent obesity by administering an acyclic amine optionally containing ether groups or a sulfide group, e.g., 2-(Dimethylamino)ethyl stearyl ether, N,N-dimethylhexadecylamine, or 2-(Diisopropylamino)ethyl dodecyl ether
09/18/2008US20080227864 Lhr1 Activators as Medicaments
09/18/2008US20080227846 Administering competitive inhibitor of mevalonate synthesis, competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (such as statin), or inducer of AMP protein kinase (AMPK) activity; sustained release
09/18/2008US20080227834 Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions
09/18/2008US20080227831 Contains N-methylnicotinamide; seaweed extracts; atherosclerosis
09/18/2008US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity
09/18/2008US20080227825 Dipeptidylpeptidase IV inhibitors such as vildagliptin and metformin; tablets
09/18/2008US20080227809 hexaquis(3-phenyl-propylamine) decavanadate (V); particularly insulin-resistant diabetes; insulin mimickers
09/18/2008US20080227798 inhibiting dipeptidyl peptidases; diabetes mellitus
09/18/2008US20080227792 3,4-Dihydro-1H-Isoquinoline-2-Carboxylic Acid 5-Aminopyridin-2-Yl Esters
09/18/2008US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy
09/18/2008US20080227786 Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
09/18/2008US20080227770 Benzoxazepine Compound
09/18/2008US20080227767 Methods and compounds for inhibiting amyloid deposits
09/18/2008US20080227753 Nutritional supplements; produced by pulverizing at cryogenic temperatures to preserve the natural components of bagasse, natural color and absorbs color evenly so that it could be used as a natural foundation material for cosmetic products
09/18/2008US20080227709 Gene expression in peripheral blood mononuclear cells from children with diabetes
09/18/2008US20080227690 Particles for inhalation having rapid release properties
09/18/2008US20080227135 Autoimmune Conditions and NADPH Oxidase Defects
09/18/2008US20080226735 For removing phosphates from blood and/or gastrointestinal tract
09/18/2008US20080226730 Particles for inhalation having rapid release properties
09/18/2008US20080226683 Potentiating clinoptilolite via saline wash and drying; medicant filler materials; removing metals, nitrates and toxins from organ tissues
09/18/2008US20080226654 Uses of mammalian cytokine; related reagents
09/18/2008US20080226653 Inhibition of Platelet Aggregation
09/18/2008US20080226646 Use of biomolecular targets in the treatment and visualization of tumors
09/18/2008US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders
09/18/2008US20080226639 Heparin Binding Peptide
09/18/2008US20080226631 Methods of modulating cytokine activity; related reagents
09/18/2008DE102007012644A1 Stabilisierung von Vitamin B12 Stabilization of vitamin B12
09/18/2008DE102007012284A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments
09/18/2008DE102006053636B4 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung New with cyclohexyl substituted 1,4-benzothiepine-1,1-dioxide derivatives and their use
09/18/2008CA2718127A1 Gene expression in peripheral blood mononuclear cells from children with diabetes
09/18/2008CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008CA2681158A1 Methods and compositions for the sustained release of chromium
09/18/2008CA2681092A1 Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition
09/18/2008CA2680938A1 Novel preventive and/or therapeutic agent for diabetic neuropathy
09/18/2008CA2680935A1 Novel preventive and/or therapeutic agent for neuropathic pain
09/18/2008CA2680665A1 Use of a barley bran for reducing visceral fat
09/18/2008CA2679975A1 Therapy for hyperglycemia, related disorders and erectile dysfunction
09/18/2008CA2679971A1 Glucokinase activator
09/18/2008CA2679884A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008CA2679866A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
09/18/2008CA2679701A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008CA2679346A1 Tricyclic isoquinoline derivatives for treatment of obesity
09/17/2008EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
09/17/2008EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism
09/17/2008EP1970063A1 Therapeutic agent for diabetes
09/17/2008EP1970051A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
09/17/2008EP1968967A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
09/17/2008EP1968962A2 Diaza heterocyclic sulfonamide derivatives and their uses
09/17/2008EP1968944A1 Alkylsulphonamide quinolines
09/17/2008EP1968941A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp)
09/17/2008EP1968644A2 Polymer conjugates of glp-1
09/17/2008EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds
09/17/2008EP1968607A1 Treatment of cancer and other diseases
09/17/2008EP1968605A1 Emulsions comprising non-esterified phytosterols in the aqueous phase
09/17/2008EP1968601A2 Salts of potassium atp channel openers and uses thereof
09/17/2008EP1968593A2 Pharmaceutical composition comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
09/17/2008EP1968576A1 Mif inhibitors
09/17/2008EP1968574A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
09/17/2008EP1968563A2 Treatment methods using triaryl methane compounds
09/17/2008EP1968561A2 Treatment of renal disorders, diabetic nephropathy and dyslipidemias
09/17/2008EP1563071B1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
09/17/2008EP1447400B1 Bicyclic compound
09/17/2008EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
09/17/2008EP1305334B1 Urocortin proteins and uses thereof
09/17/2008EP0712303B2 Skin patches comprising testosterone and optionally estrogen
09/17/2008CN101268096A Y2 selective receptor agonists for therapeutic interventions
09/17/2008CN101268075A Substituted tetrahydro-1H-pyrido[4,3-B]indoles as serotonin receptors agonists and antagonists
09/17/2008CN101268073A Heterocyclic compound, and production process and use thereof
09/17/2008CN101268063A Thiophene derivatives for the treatment of diabetes
09/17/2008CN101268047A Crystalline and amorphous sodium atorvastatin
09/17/2008CN101267823A Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
09/17/2008CN101267817A Amino acid and its uses
09/17/2008CN101265251A Method for extracting naringenin from Chinese medicament chinaroot greenbrier and application thereof
09/17/2008CN101264331A New purpose of Chinese medicine almond
09/17/2008CN101264319A Preparation of exenatide freeze-drying preparation